Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
PUT
Elevance Health
ELV
$84.9B
| $18.6M | 0.01% |
40,200
+16,200
| +68% | +$6.82M |
|
977
PUT
SLB Ltd
SLB
$76.5B
| $18.5M | 0.01% |
617,600
-138,800
| -18% | -$4.37M |
|
978
A.O. Smith
AOS
$8.56B
| $18.4M | 0.01% |
214,506
-124,924
| -37% | -$9.52M |
|
979
PVH
PVH
$3.99B
| $18.4M | 0.01% |
172,249
+107,552
| +166% | +$11.8M |
|
|
GAP
980
The Gap Inc
GAP
$7.39B
| $18.4M | 0.01% |
1,040,379
-954,985
| -48% | -$20M |
|
981
CALL
ExxonMobil
XOM
$642B
| $18.4M | 0.01% |
300,000
-460,600
| -61% | -$28.8M |
|
982
Arch Capital
ACGL
$33.9B
| $18.2M | 0.01% |
410,252
-151,146
| -27% | -$6.41M |
|
983
Universal Display
OLED
$4.01B
| $18.2M | 0.01% |
110,356
+52,568
| +91% | +$8.67M |
|
|
AZPN
984
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $18.1M | 0.01% |
119,031
-11,151
| -9% | -$1.7M |
|
985
Silicon Laboratories
SLAB
$7.21B
| $18M | 0.01% |
87,202
+14,886
| +21% | +$2.74M |
|
986
Enovis
ENOV
$1.51B
| $18M | 0.01% |
227,034
+93,260
| +70% | +$7.8M |
|
987
PUT
eBay
EBAY
$48.9B
| $18M | 0.01% |
270,000
+250,000
| +1,250% | +$17.8M |
|
988
CALL
First Solar
FSLR
$26.2B
| $17.8M | 0.01% |
204,700
-34,100
| -14% | -$3.51M |
|
989
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$30.4M
| $17.8M | 0.01% |
172,811
+150,000
| +658% | +$15.7M |
|
|
990
CALL
SLB Ltd
SLB
$76.5B
| $17.8M | 0.01% |
593,500
| – | – |
|
991
SM Energy
SM
$6.88B
| $17.7M | 0.01% |
601,552
+9,696
| +2% | +$303K |
|
992
Arrowhead Research
ARWR
$12.1B
| $17.7M | 0.01% |
267,322
+49,938
| +23% | +$3.43M |
|
993
Parsons
PSN
$5.12B
| $17.7M | 0.01% |
525,590
+24,242
| +5% | +$841K |
|
994
CALL
Vertex Pharmaceuticals
VRTX
$123B
| $17.7M | 0.01% |
+80,400
| New | +$15.6M |
|
995
Rio Tinto
RIO
$162B
| $17.6M | 0.01% |
262,727
-38,782
| -13% | -$2.51M |
|
996
Vanguard FTSE Europe ETF
VGK
$31.1B
| $17.6M | 0.01% |
257,340
-356,974
| -58% | -$24.2M |
|
997
BioMarin Pharmaceuticals
BMRN
$11.9B
| $17.5M | 0.01% |
198,359
-10,771
| -5% | -$889K |
|
998
CALL
AT&T
T
$162B
| $17.5M | 0.01% |
942,953
+76,527
| +9% | +$1.43M |
|
999
StoneCo
STNE
$2.69B
| $17.5M | 0.01% |
1,037,029
+894,113
| +626% | +$22.7M |
|
1000
Pentair
PNR
$11.2B
| $17.4M | 0.01% |
238,575
+3,414
| +1% | +$252K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.